Treatment of congenital toxoplasmosis.
Wilson
C B
CB
University of Washington, Seattle.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011739:Pyrimethamine / Q000627:therapeutic use*; D015572:Spiramycin / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use*; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D013411:Sulfadiazine; D015572:Spiramycin; D011739:Pyrimethamine